Cognition Therapeutics, Inc. (NASDAQ:CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders including dementia with Lewy bodies (DLB), had the opportunity to raise ...
Credit: Getty Images Nonmodifiable risk factors for DLB include age and family history. Risk increases substantially in individuals with a first-degree relative who has DLB, including a 2-fold ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results